ArticlePloS one2018

Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma.

Hayley M Reynolds et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.